Drug Profile
Research programme: topical NSAIDs - Achelios Therapeutics
Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Achelios Therapeutics
- Class Analgesics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Prostaglandin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Osteoarthritis; Sprains
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Osteoarthritis in USA (Topical)
- 31 Aug 2023 Discontinued - Preclinical for Sprains in USA (Topical)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Osteoarthritis in USA (Topical, Gel)